Rs 77.09 10 % Off
Package size
Estimate Delivery by:
Delivering to
Easy 7 days return available
Voglibite M 0.2 mg Tablets are formulated to address symptoms associated with vestibular disorders and Meniere's disease. Each tablet contains 0.2 mg of Betahistine dihydrochloride, a medication that works by enhancing blood flow to the inner ear. This helps to alleviate common symptoms such as dizziness, vertigo, and tinnitus by stabilizing inner ear pressure and improving overall inner ear function. The tablets are designed for ease of ingestion and accurate dosing, making them convenient for daily use. Packaged in a 10-tablet bottle, Voglibite M is suitable for short-term relief or as part of a longer-term treatment regimen. By targeting the underlying causes of vestibular symptoms, Voglibite M helps improve the quality of life for individuals affected by these conditions.
Active Ingredient: Contains 0.2 mg of Betahistine dihydrochloride, used for the management of vestibular disorders and Meniere's disease. Symptom Relief: Designed to alleviate symptoms such as dizziness, vertigo, and tinnitus associated with inner ear conditions. Enhances Inner Ear Circulation: Improves blood flow to the inner ear, helping to stabilize symptoms by addressing inner ear pressure and function. Convenient Tablet Form: Easy-to-swallow tablets ensure precise dosing and are convenient for daily use. 10-Tablet Pack: Available in a pack of 10 tablets, providing a practical quantity for short-term management or as part of a prescribed treatment plan.
VOGLIBITE M 0.2MG helps manage blood sugar levels through its components. Metformin works by decreasing the amount of glucose released into the blood by the liver, while voglibose reversibly inhibits various carbohydrate-digesting enzymes (such as sucrose, maltose, and isomaltase) in the gut. This leads to delayed digestion and absorption of glucose into the bloodstream.
Take VOGLIBITE M 0.2MG TABLET as directed by your physician. Swallow the tablet with a glass of water; do not crush or chew it. Your doctor will determine the appropriate dose and duration based on your age, body weight, and medical condition.
PREGNANCY VOGLIBITE M 0.2MG TABLET is not recommended for pregnant women. Consult your doctor before use. BREASTFEEDING VOGLIBITE M 0.2MG TABLET is not recommended for breastfeeding women. Consult your doctor before use. DRIVING AND USING MACHINES VOGLIBITE M 0.2MG TABLET does not directly affect your ability to drive or operate machinery, but it may cause hypoglycemia (low blood sugar). Be aware of symptoms such as weakness, dizziness, rapid heartbeat, vision problems, or difficulty concentrating. Do not drive or use machinery if you experience these symptoms. ALCOHOL Avoid alcohol while taking VOGLIBITE M 0.2MG TABLET, as it may increase the risk of lactic acidosis, dizziness, or drowsiness. Consult your doctor for guidance. KIDNEY VOGLIBITE M 0.2MG TABLET is not recommended for patients with severe kidney disease. Consult your doctor before use. LIVER VOGLIBITE M 0.2MG TABLET is not recommended for patients with liver problems. Consult your doctor before use. ALLERGY Do not use VOGLIBITE M 0.2MG TABLET if you are allergic to Metformin or Voglibose. HEART DISEASE VOGLIBITE M 0.2MG TABLET is not recommended for patients with heart conditions such as recent heart attack, heart failure, cardiogenic shock, or abnormal breathing. Consult your doctor before use. USE IN PEDIATRICS VOGLIBITE M 0.2MG TABLET is generally not recommended for children and adolescents under 18 years due to insufficient safety and effectiveness data. Consult your doctor before use. USE IN GERIATRICS Use VOGLIBITE M 0.2MG TABLET with caution in elderly patients aged 65 and above. Treatment should usually start at a lower dose, and kidney function may need to be monitored more frequently. Consult your doctor before use.
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s